1.4101
price down icon0.97%   -0.0299
 
loading
Schlusskurs vom Vortag:
$1.44
Offen:
$1.44
24-Stunden-Volumen:
348.72K
Relative Volume:
0.60
Marktkapitalisierung:
$1.14M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-20.26M
KGV:
-0.1651
EPS:
-8.54
Netto-Cashflow:
$-8.25M
1W Leistung:
-0.28%
1M Leistung:
-60.50%
6M Leistung:
-84.52%
1J Leistung:
-95.52%
1-Tages-Spanne:
Value
$1.40
$1.4934
1-Wochen-Bereich:
Value
$1.31
$1.4934
52-Wochen-Spanne:
Value
$1.30
$75.60

Oragenics Inc Stock (OGEN) Company Profile

Name
Firmenname
Oragenics Inc
Name
Telefon
813-286-7900
Name
Adresse
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Name
Mitarbeiter
6
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
OGEN's Discussions on Twitter

Vergleichen Sie OGEN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
OGEN
Oragenics Inc
1.4394 1.14M 0 -20.26M -8.25M -8.54
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
473.41 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.71 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.06 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
589.38 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.02 31.99B 3.81B -644.79M -669.77M -6.24

Oragenics Inc Aktie (OGEN) Neueste Nachrichten

pulisher
Jul 23, 2025

What drives Oragenics Inc. stock priceSuperior capital gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Oragenics Inc. Stock Analysis and ForecastExceptional return forecasts - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Oragenics Inc. stockOutstanding stock performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Oragenics Inc. a good long term investmentPhenomenal returns - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Why Oragenics Inc. stock attracts strong analyst attention5x Profit Potential - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Oragenics Announces Approval of Common Stock Listing on NYSE MKT - AOL.com

Jul 22, 2025
pulisher
Jul 16, 2025

Oragenics Partners With Sterling For U.S.-Based Manufacturing Of Concussion Drug ONP-002 - Nasdaq

Jul 16, 2025
pulisher
Jul 16, 2025

Oragenics Inc. Secures U.S. Manufacturing Partner for Concussion Drug Ahead of Phase IIb Trials - citybuzz -

Jul 16, 2025
pulisher
Jul 16, 2025

Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical Development - The Manila Times

Jul 16, 2025
pulisher
Jul 16, 2025

Oragenics partners with Sterling for concussion drug production By Investing.com - Investing.com South Africa

Jul 16, 2025
pulisher
Jul 16, 2025

Oragenics partners with Sterling for concussion drug production - Investing.com

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Oragenics Inc. stock price move sharplyHigh Probability Setups - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Oragenics Inc. stock performs during market volatilityFree Real-Time Market Predictions - Newser

Jul 15, 2025
pulisher
Jul 07, 2025

Best Momentum Stock to Buy for July 7th - The Globe and Mail

Jul 07, 2025
pulisher
Jul 03, 2025

Oragenics Soars 11.11% on $20M Capital Raise for Clinical Trials - AInvest

Jul 03, 2025
pulisher
Jul 02, 2025

Oragenics Closes $16.5 Million Offering of Preferred Stock, Warrants - MarketScreener

Jul 02, 2025
pulisher
Jul 02, 2025

Oragenics Raises $16.5M Through Public Offering - TipRanks

Jul 02, 2025
pulisher
Jul 02, 2025

Oragenics, Inc. Successfully Closes $16.5 Million Public Offering of Series H Convertible Preferred Stock and Warrants - Nasdaq

Jul 02, 2025
pulisher
Jul 02, 2025

Oragenics' Stock Takes A Hit With New Offering Announcement - Finimize

Jul 02, 2025
pulisher
Jul 02, 2025

Form 424B5 ORAGENICS INC - StreetInsider

Jul 02, 2025
pulisher
Jul 02, 2025

Oragenics shares plunge following announcement of $20 million preferred stock sale - MSN

Jul 02, 2025
pulisher
Jul 01, 2025

Oragenics Inc. Announces $20 Million Preferred Stock and Warrant Offering to Fund Concussion Trials and R&D - citybuzz -

Jul 01, 2025
pulisher
Jul 01, 2025

Oragenics stock tumbles after announcing $20 million preferred stock offering - Investing.com

Jul 01, 2025
pulisher
Jul 01, 2025

Why Is Oragenics Stock (OGEN) Down 55% Today? - TipRanks

Jul 01, 2025
pulisher
Jul 01, 2025

Oragenics announces $20 million preferred stock offering - Investing.com Australia

Jul 01, 2025
pulisher
Jul 01, 2025

Oragenics, Inc. Announces $20 Million Public Offering of Series H Convertible Preferred Stock and Warrants - Nasdaq

Jul 01, 2025
pulisher
Jul 01, 2025

Oragenics announces $20 million preferred stock offering By Investing.com - Investing.com UK

Jul 01, 2025
pulisher
Jul 01, 2025

Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants - TradingView

Jul 01, 2025
pulisher
Jun 18, 2025

Major Shareholder Odyssey Health Sells Oragenics Stock! - TipRanks

Jun 18, 2025
pulisher
Jun 11, 2025

Future of Oral Probiotic Supplements | Innovations in Oral - openPR.com

Jun 11, 2025
pulisher
Jun 11, 2025

Oragenics Inc. to Showcase Concussion Treatment Candidate at Major 2025 Conferences - citybuzz -

Jun 11, 2025
pulisher
Jun 10, 2025

Oragenics to Present at 2025 BIO International Convention and At - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Oragenics, Inc. to Present ONP-002 at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium - Nasdaq

Jun 10, 2025
pulisher
Jun 10, 2025

GlobeNewswire by Notified - The Manila Times

Jun 10, 2025
pulisher
Jun 10, 2025

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium | OGEN Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium - The Manila Times

Jun 10, 2025
pulisher
Jun 10, 2025

Pre-market Movers: EVGN, WINT, CARM, UNCY... - RTTNews

Jun 10, 2025
pulisher
Jun 10, 2025

Oragenics to Present at 2025 BIO International Convention - GlobeNewswire

Jun 10, 2025

Finanzdaten der Oragenics Inc-Aktie (OGEN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.64
price up icon 3.26%
$36.65
price up icon 1.75%
$103.53
price up icon 0.18%
$27.62
price down icon 1.50%
$114.43
price down icon 0.13%
biotechnology ONC
$296.02
price up icon 0.18%
Kapitalisierung:     |  Volumen (24h):